More than seven months after President Trump issued an executive order requiring federal agencies to remove two regulations for every regulation they implement, known as the two-for-one rule, US FDA is asking stakeholders for input on which regulations to withdraw.
In separate notices addressing each product center of FDA, the agency issued identical request for broad stakeholder input on how to reduce regulatory burdens in accordance with the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?